Novonesis Statistics
Total Valuation
Novonesis has a market cap or net worth of 26.43 billion. The enterprise value is 28.23 billion.
| Market Cap | 26.43B |
| Enterprise Value | 28.23B |
Important Dates
The next estimated earnings date is Wednesday, February 26, 2025.
| Earnings Date | Feb 26, 2025 |
| Ex-Dividend Date | Sep 9, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.26% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 345.19M |
Valuation Ratios
The trailing PE ratio is 87.23.
| PE Ratio | 87.23 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 33.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 34.73, with an EV/FCF ratio of 41.72.
| EV / Earnings | 93.16 |
| EV / Sales | 8.92 |
| EV / EBITDA | 34.73 |
| EV / EBIT | 52.06 |
| EV / FCF | 41.72 |
Financial Position
The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.18.
| Current Ratio | 1.11 |
| Quick Ratio | 0.67 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 2.53 |
| Debt / FCF | 3.15 |
| Interest Coverage | 11.54 |
Financial Efficiency
Return on equity (ROE) is 4.38% and return on invested capital (ROIC) is 4.12%.
| Return on Equity (ROE) | 4.38% |
| Return on Assets (ROA) | 3.45% |
| Return on Capital (ROIC) | 4.12% |
| Revenue Per Employee | 312,121 |
| Profits Per Employee | 28,990 |
| Employee Count | 6,756 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 2.66 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.59% in the last 52 weeks. The beta is 0.52, so Novonesis's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | +3.59% |
| 50-Day Moving Average | 60.23 |
| 200-Day Moving Average | 61.89 |
| Relative Strength Index (RSI) | 40.10 |
| Average Volume (20 Days) | 17,064 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novonesis had revenue of 3.26 billion and earned 303.00 million in profits. Earnings per share was 1.09.
| Revenue | 3.26B |
| Gross Profit | 1.52B |
| Operating Income | 562.57M |
| Pretax Income | 393.62M |
| Net Income | 303.00M |
| EBITDA | 714.95M |
| EBIT | 562.57M |
| Earnings Per Share (EPS) | 1.09 |
Balance Sheet
The company has 279.44 million in cash and 2.13 billion in debt, giving a net cash position of -1.85 billion.
| Cash & Cash Equivalents | 279.44M |
| Total Debt | 2.13B |
| Net Cash | -1.85B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 11.79B |
| Book Value Per Share | 42.42 |
| Working Capital | 189.65M |
Cash Flow
In the last 12 months, operating cash flow was 954.62 million and capital expenditures -277.95 million, giving a free cash flow of 676.67 million.
| Operating Cash Flow | 954.62M |
| Capital Expenditures | -277.95M |
| Free Cash Flow | 676.67M |
| FCF Per Share | n/a |
Margins
Gross margin is 46.66%, with operating and profit margins of 17.24% and 9.29%.
| Gross Margin | 46.66% |
| Operating Margin | 17.24% |
| Pretax Margin | 12.07% |
| Profit Margin | 9.29% |
| EBITDA Margin | 21.92% |
| EBIT Margin | 17.24% |
| FCF Margin | 20.74% |
Dividends & Yields
This stock pays an annual dividend of 0.35, which amounts to a dividend yield of 0.62%.
| Dividend Per Share | 0.35 |
| Dividend Yield | 0.62% |
| Dividend Growth (YoY) | -63.27% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 99.19% |
| Buyback Yield | 0.26% |
| Shareholder Yield | 0.88% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
The last stock split was on December 9, 2011. It was a forward split with a ratio of 5.
| Last Split Date | Dec 9, 2011 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
Novonesis has an Altman Z-Score of 3.78.
| Altman Z-Score | 3.78 |
| Piotroski F-Score | n/a |